|
MLYS Mineralys Therapeutics Inc 1933414 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-39,339,000.00 |
| Balance Sheet |
|
Current Assets
|
$652,470,000.00 |
|
Assets
|
$652,862,000.00 |
|
Current Liabilities
|
$14,718,000.00 |
|
Equity
|
$638,144,000.00 |
|
Shares Out
|
82454950.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-39,471,000.00 |
|
Investing Cash Flow
|
$-44,943,000.00 |
| Market Analysis |
Market Cap
|
$2,159,495,140.50 |
|
Price
|
$25.10 |
|
BVPS
|
7.74 |
|
PB
|
3.38 |
|
EPS
|
-0.47 |
|
FCF
|
$-39,486,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:17 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.40 |
|
|
2026-05-06 |
-0.47 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.66 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.52 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MLYS documents filed with the SEC.
MLYS Filings
Clear
